250
Views
13
CrossRef citations to date
0
Altmetric
Review

Cardiopulmonary exercise testing – refining the clinical perspective by combining assessments

, , , , , ORCID Icon & show all
Pages 563-576 | Received 09 Jun 2020, Accepted 03 Aug 2020, Published online: 20 Aug 2020

References

  • Ross R, Blair SN, Arena R, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American heart association. Circulation. 2016;134(24):e653–e699.
  • Guazzi M, Adams V, Conraads V, et al. Eacpr and Aha. EACPR/AHA joint scientific statement. clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2012;33:2917–2927.
  • Guazzi M, Arena R, Halle M, et al. focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2016;2018(39):1144–1161.
  • Weisman IM, Weisman IM, Marciniuk D, et al. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167: 1451. author reply 1451-1451; author reply 1451.
  • Balady GJ, Arena R, Sietsema K, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: A scientific statement from the American heart association. Circulation. 2010;122:191–225.
  • Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American heart association. Circulation. 2013;128:873–934.
  • Arena R, Myers J, Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev. 2008;13:245–269.
  • Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29:185–209.
  • Puente-Maestu L, Palange P, Casaburi R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47:429–460.
  • Guazzi M, Bandera F, Ozemek C, et al. Cardiopulmonary exercise testing: what is its value? J Am College Cardiol. 2017;70:1618–1636.
  • Corrà U, Agostoni PG, Anker SD, et al. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the committee on exercise physiology and training of the heart failure association of the European society of cardiology. Eur J Heart Fail. 2018;20:3–15.
  • Myers J, Arena R, Cahalin LP, et al. Cardiopulmonary exercise testing in heart failure. Curr Probl Cardiol. 2015;40(8):322–372.
  • O’Donnell DE, Milne KM, Vincent SG and Neder JA. Unraveling the causes of unexplained dyspnea: the value of exercise testing. Clin Chest Med. 2019;40:471–499.
  • Palange P, Carlone S, Forte S, et al. Cardiopulmonary exercise testing in the evaluation of patients with ventilatory vs circulatory causes of reduced exercise tolerance. Chest. 1994;105:1122–1126.
  • Arena R. Exercise testing and training in chronic lung disease and pulmonary arterial hypertension. Prog Cardiovasc Dis. 2011;53:454–463.
  • Radtke T, Crook S, Kaltsakas G, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev. 2019;28(154):180101.
  • Khan AM, Paridon SM, Kim YY. Cardiopulmonary exercise testing in adults with congenital heart disease. Expert Rev Cardiovasc Ther. 2014;12:863–872.
  • Mantegazza V, Apostolo A, Hager A. Cardiopulmonary exercise testing in adult congenital heart disease. Ann Am Thorac Soc. 2017;14:S93–S101.
  • Rowin EJ, Maron BJ, Olivotto I, et al. Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10:1374–1386.
  • Magrì D, Santolamazza C. Cardiopulmonary exercise test in hypertrophic cardiomyopathy. Ann Am Thorac Soc. 2017;14:S102–S109.
  • Farina S, Correale M, Bruno N, et al. The role of cardiopulmonary exercise tests in pulmonary arterial hypertension. Eur Respir Rev. 2018;27(148):170134.
  • Pinkstaff SO, Burger CD, Daugherty J, et al. Cardiopulmonary exercise testing in patients with pulmonary hypertension: clinical recommendations based on a review of the evidence. Expert Rev Resp Med. 2016;10:279–295.
  • Moran J, Wilson F, Guinan E, et al. Role of cardiopulmonary exercise testing as a risk-assessment method in patients undergoing intra-abdominal surgery: a systematic review. Br J Anaesth. 2016;116:177–191.
  • Older PO, Levett DZH. Cardiopulmonary exercise testing and surgery. Ann Am Thorac Soc. 2017;14:S74–S83.
  • Jones LW, Eves ND, Haykowsky M, et al. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol. 2008;9:757–765.
  • Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation: including pathophysiology and clinical applications. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
  • Oliveira RB, Myers J, Araujo CG, et al. Does peak oxygen pulse complement peak oxygen uptake in risk stratifying patients with heart failure? Am J Cardiol. 2009;104:554–558.
  • Johnson BD, Weisman IM, Zeballos RJ, et al. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest. 1999;116:488–503.
  • Myers J, Oliveira R, Dewey F, et al. Validation of a cardiopulmonary exercise test score in heart failure. Circ Heart Fail. 2013;6:211–218.
  • Wilkoff BL, Miller RE. Exercise testing for chronotropic assessment. Cardiol Clin. 1992;10:705–717.
  • Khan MN, Pothier CE, Lauer MS. Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol). Am J Cardiol. 2005;96:1328–1333.
  • Sydo N, Sydo T, Gonzalez Carta KA, et al. Prognostic performance of heart rate recovery on an exercise test in a primary prevention population. J Am Heart Assoc. 2018;7(7):e008143.
  • Pinkstaff S, Peberdy MA, Kontos MC, et al. Quantifying exertion level during exercise stress testing using percentage of age-predicted maximal heart rate, rate pressure product, and perceived exertion. Mayo Clin Proc. 2010;85:1095–1100.
  • Cole JP, Ellestad MH. Significance of chest pain during treadmill exercise: correlation with coronary events. Am J Cardiol. 1978;41:227–232.
  • Guazzi M, Myers J, Peberdy MA, et al. Maximal dyspnea on exertion during cardiopulmonary exercise testing is related to poor prognosis and echocardiography with tissue Doppler imaging in heart failure. Congest Heart Fail. 2009;15:277–283.
  • Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–2667.
  • Agostoni P, Corrà U, Cattadori G, et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013;167:2710–2718.
  • Ingle L, Rigby AS, Sloan R, et al. Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failure. Heart. 2014;100:781–786.
  • Moneghetti KJ, Christle JW, Myers J, et al. Exercise testing in heart failure: a contemporary discussion in an era of novel diagnostic techniques and biomarkers. Curr Opin Cardiol. 2018;33:217–224.
  • Bensimhon DR, Leifer ES, Ellis SJ, et al. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the heart failure and a controlled trial investigating outcomes of exercise traiNing). Am J Cardiol. 2008;102:712–717.
  • Alba AC, Adamson MW, MacIsaac J, et al. The added value of exercise variables in heart failure prognosis. J Card Fail. 2016;22:492–497.
  • Davies LC, Wensel R, Georgiadou P, et al. Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J. 2006;27:684–690.
  • Goulart C, Dos Santos PB, Caruso FR, et al. The value of cardiopulmonary exercise testing in determining severity in patients with both systolic heart failure and COPD. Sci Rep. 2020;10:4309.
  • Tsai Y-J, Li M-H, Tsai W-J, et al. Oxygen uptake efficiency slope and peak oxygen consumption predict prognosis in children with tetralogy of Fallot. Eur J Prev Cardiol. 2016;23:1045–1050.
  • Akkerman M, van Brussel M, Hulzebos E, et al. The oxygen uptake efficiency slope: what do we know? J Cardiopulm Rehabil. 2010;30:357–373.
  • Berger T, Zwick RH, Stuehlinger M, et al. Impact of oxygen uptake efficiency slope as a marker of cardiorespiratory reserve on response to cardiac resynchronization therapy. Clin Res Cardiol. 2011;100:159–166.
  • Buys R, Coeckelberghs E, Cornelissen VA, et al. Prognostic value of the post-training oxygen uptake efficiency slope in patients with coronary artery disease. Eur J Prev Cardiol. 2016;23:1363–1371.
  • Guazzi M, Arena R, Halle M, et al. Focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2016;2016(133):e694–711.
  • Santoro C, Sorrentino R, Esposito R, et al. Cardiopulmonary exercise testing and echocardiographic exam: an useful interaction. Cardiovasc Ultrasound. 2019;17:29.
  • Guazzi M. Stress echocardiography combined with cardiopulmonary exercise testing: opening a new window into diagnosis of heart failure with preserved ejection fraction. Eur J Prev Cardiol. 2016;23:67–70.
  • Bandera F, Generati G, Pellegrino M, et al. Role of right ventricle and dynamic pulmonary hypertension on determining DeltaVO2/DeltaWork Rate flattening: insights from cardiopulmonary exercise test combined with exercise echocardiography. Circ Heart Fail. 2014;7:782–790.
  • Myers J, Wong M, Adhikarla C, et al. Cardiopulmonary and noninvasive hemodynamic responses to exercise predict outcomes in heart failure. J Card Fail. 2013;19:101–107.
  • Finocchiaro G, Haddad F, Knowles JW, et al. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. JACC Heart Fail. 2015;3:408–418.
  • Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the European association of, cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 17(412):2016.
  • Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;2016(18):891–975.
  • Shimiaie J, Sherez J, Aviram G, et al. Determinants of effort intolerance in patients with heart failure: combined echocardiography and cardiopulmonary stress protocol. JACC Heart Fail. 2015;3:803–814.
  • Pugliese NR, Fabiani I, Santini C, et al. Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction. Eur Heart J Cardiovasc Imaging. 2019;20:828–836.
  • Hasselberg NE, Haugaa KH, Sarvari SI, et al. Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction. Eur Heart J Cardiovasc Imaging. 2015;16:217–224.
  • Popovic D, Arena R, Guazzi M. A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction. Eur J Heart Fail. 2018;20:1115–1124.
  • Lancellotti P, Dulgheru R, Go YY, et al. Stress echocardiography in patients with native valvular heart disease. Heart. 2018;104:807–813.
  • Burgess MI, Jenkins C, Sharman JE, et al. Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol. 2006;47:1891–1900.
  • Ha JW, Oh JK, Pellikka PA, et al. Diastolic stress echocardiography: a novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiography. J Am Soc Echocardiogr. 2005;18:63–68.
  • Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539–2550.
  • Podolec P, Rubís P, Tomkiewicz-Pajak L, et al. Usefulness of the evaluation of left ventricular diastolic function changes during stress echocardiography in predicting exercise capacity in patients with ischemic heart failure. J Am Soc Echocardiogr. 2008;21:834–840.
  • Goda A, Lang CC, Williams P, et al. Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure. Am J Cardiol. 2009;104:1556–1560.
  • Williams SG, Jackson M, Cooke GA, et al. Albuoaini K and Tan LB. How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure? Am Heart J. 2005;150:983.
  • Myers J, Gujja P, Neelagaru S, et al. Cardiac output and cardiopulmonary responses to exercise in heart failure: application of a new bio-reactance device. J Card Fail. 2007;13:629–636.
  • van Riel AC, Opotowsky AR, Santos M, et al. Accuracy of echocardiography to estimate pulmonary artery pressures with exercise: a simultaneous invasive-noninvasive comparison. Circ Cardiovasc Imaging. 2017;10(4):e005711.
  • Pugliese NR, Fabiani I, Mandoli GE, et al. Echo-derived peak cardiac power output-to-left ventricular mass with cardiopulmonary exercise testing predicts outcome in patients with heart failure and depressed systolic function. Eur Heart J Cardiovasc Imaging. 2019;20:700–708.
  • Tanabe Y, Nakagawa I, Ito E, et al. Hemodynamic basis of the reduced oxygen uptake relative to work rate during incremental exercise in patients with chronic heart failure. Int J Cardiol. 2002;83:57–62.
  • Belardinelli R, Lacalaprice F, Carle F, et al. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J. 2003;24:1304–1313.
  • Lancellotti P, Magne J, Dulgheru R, et al. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. Am J Cardiol. 2015;115:1454–1461.
  • Sugimoto T, Bandera F, Generati G, et al. Left atrial function dynamics during exercise in heart failure: pathophysiological implications on the right heart and exercise ventilation inefficiency. JACC Cardiovasc Imaging. 2017;10:1253–1264.
  • Galiè N, Humbert M, Vachiery J-L, et al. “2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS. Eur Respir J. 2015;46:903–975. The European respiratory journal. 2015;46:1855-6.
  • Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European association of cardiovascular imaging and the American society of echocardiography. J Am Soc Echocardiogr. 2017;30:101–138.
  • Held M, Grün M, Holl R, et al. Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration. 2014;87:379–387.
  • Grunig E, Tiede H, Enyimayew EO, et al. Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation. 2013;128:2005–2015.
  • Galderisi M, Cardim N, D’Andrea A, et al. The multi-modality cardiac imaging approach to the Athlete’s heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:353.
  • Sharma S, Elliott PM, Whyte G, et al. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol. 2000;36:864–870.
  • Hamatani Y, Amaki M, Yonezawa R, et al. Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2019;35:837–844.
  • Nistri S, Olivotto I, Maron MS, et al. Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy. Am J Cardiol. 2010;106:1301–1306.
  • Moneghetti KJ, Kobayashi Y, Christle JW, et al. Contractile reserve and cardiopulmonary exercise parameters in patients with dilated cardiomyopathy, the two dimensions of exercise testing. Echocardiography. 2017;34:1179–1186.
  • Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;2017(70):252–289.
  • Goublaire C, Melissopoulou M, Lobo D, et al. Prognostic value of exercise-stress echocardiography in asymptomatic patients with aortic valve stenosis. JACC Cardiovasc Imaging. 2018;11:787–795.
  • Pierard LA, Dulgheru R. Exercise testing and stress imaging in aortic valve disease. Curr Treat Options Cardiovasc Med. 2017;19:54.
  • Le VDT. Cardiopulmonary Exercise Testing in Aortic Stenosis. Dan Med J. 2017;65(5):B5353.
  • Broch K, Urheim S, Massey R, et al. Exercise capacity and peak oxygen consumption in asymptomatic patients with chronic aortic regurgitation. Int J Cardiol. 2016;223:688–692.
  • Laufer-Perl M, Gura Y, Shimiaie J, et al. Mechanisms of effort intolerance in patients with rheumatic mitral stenosis: combined echocardiography and cardiopulmonary stress protocol. JACC Cardiovasc Imaging. 2017;10:622–633.
  • Utsunomiya H, Hidaka T, Susawa H, et al. Exercise-stress echocardiography and effort intolerance in asymptomatic/minimally symptomatic patients with degenerative mitral regurgitation combined invasive-noninvasive hemodynamic monitoring. Circ Cardiovasc Imaging. 2018;11:e007282.
  • Guazzi M, Bandera F, Ozemek C, et al. Cardiopulmonary exercise testing: what is its value? J Am Coll Cardiol. 2017;70:1618–1636.
  • Popovic D, Guazzi M, Jakovljevic DG, et al. Quantification of coronary artery disease using different modalities of cardiopulmonary exercise testing. Int J Cardiol. 2019;285:11–13.
  • Popovic D, Martic D, Djordjevic T, et al. Oxygen consumption and carbon-dioxide recovery kinetics in the prediction of coronary artery disease severity and outcome. Int J Cardiol. 2017;248:39–45.
  • Kullo IJ, Khaleghi M, Hensrud DD. Markers of inflammation are inversely associated with VO2 max in asymptomatic men. J Appl Physiol (1985). 2007;102:1374–1379.
  • Felker GM, Whellan D, Kraus WE, et al. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION) study. Am Heart J. 2009;158:S37–44.
  • van Wezenbeek J, Canada JM, Ravindra K, et al. C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of ejection fraction. Front Cardiovasc Med. 2018;5:178.
  • Canada JM, Fronk DT, Cei LF, et al. Usefulness of C-reactive protein plasma levels to predict exercise intolerance in patients with chronic systolic heart failure. Am J Cardiol. 2016;117:116–120.
  • Ahmad T, Fiuzat M, Mark DB, et al. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. Am Heart J. 2014;167:193–202.e1.
  • Del Buono MG, Arena R, Borlaug BA, et al. Exercise intolerance in patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:2209–2225.
  • Van Tassell BW, Trankle CR, Canada JM, et al. IL-1 blockade in patients with heart failure with preserved ejection fraction. Circ Heart Fail. 2018;11(8):e005036.
  • Van Tassell BW, Canada J, Carbone S, et al. Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial). Circ Heart Fail. 2017;10(11):e004373.
  • van Wezenbeek J, Canada JM, Ravindra K, et al. Determinants of cardiorespiratory fitness in patients with heart failure across a wide range of ejection fractions. Am J Cardiol. 2020;125:76–81.
  • Maeder M, Wolber T, Rickli H, et al. Weilenmann D and Ammann P. B-type natriuretic peptide kinetics and cardiopulmonary exercise testing in heart failure. Int J Cardiol. 2007;120:391–398.
  • Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010;121:692–705.
  • Kettenbach J, Kacher DF, Kanan AR, et al. Intraoperative and interventional MRI: recommendations for a safe environment. Minimally Invasive Ther Allied Technol. 2006;15:53–64.
  • Myers J, Arena R, Franklin B, et al. Recommendations for clinical exercise laboratories: a scientific statement from the american heart association. Circulation. 2009;119:3144–3161.
  • Rerkpattanapipat P, Gandhi SK, Darty SN, et al. Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am J Cardiol. 2003;92:603–606.
  • Jekic M, Foster EL, Ballinger MR, et al. Cardiac function and myocardial perfusion immediately following maximal treadmill exercise inside the MRI room. J Cardiovasc Magn Reson. 2008;10:1–10.
  • Foster EL, Arnold JW, Jekic M, et al. MR-compatible treadmill for exercise stress cardiac magnetic resonance imaging. Magn Reson Med. 2012;67:880–889.
  • Raman SV, Dickerson JA, Mazur W, et al. Diagnostic performance of treadmill exercise cardiac magnetic resonance: the prospective, multicenter exercise CMR’s accuracy for cardiovascular stress testing (EXACT) trial. J Am Heart Assoc. 2016;5:1–11.
  • Niezen RA, Doornbos J, Van Der Wall EE, et al. Measurement of aortic and pulmonary flow with mri at rest and during physical exercise. J Comput Assist Tomogr. 1998;22:194–201.
  • Beaudry RI, Samuel TJ, Wang J, et al. Exercise cardiac magnetic resonance imaging: a feasibility study and meta-analysis. Am J Physiol Regul Integr Comp Physiol. 2018;315:R638–R645.
  • Forouzan O, Warczytowa J, Wieben O, et al. Non-invasive measurement using cardiovascular magnetic resonance of changes in pulmonary artery stiffness with exercise. J Cardiovasc Magn Reson. 2015;17:1–10.
  • Barber NJ, Ako EO, Kowalik GT, et al. MR augmented cardiopulmonary exercise testing - A novel approach to assessing cardiovascular function. Physiol Meas. 2015;36:N85–N94.
  • Myers J, Buchanan N, Walsh D, et al. Comparison of the Ramp Versus Standard Exercise Protocols. J Am Coll Cardiol. 1991;17:1334–1342.
  • Claessen G, Gerche AL, Wielandts JY, et al. Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension. Heart. 2015;101:637–644.
  • La Gerche A, Claessen G, Dymarkowski S, et al. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J. 2015;36:1998–2010.
  • Howden EJ, Bigaran A, Beaudry R, et al. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol. 2019;26:305–315.
  • Lafountain RA, Da Silveira JS, Varghese J, et al. Cardiopulmonary exercise testing in the MRI environment. Physiol Meas. 2016;37:N11–N25.
  • Reding KW, Brubaker P, D’Agostino R, et al. Increased skeletal intermuscular fat is associated with reduced exercise capacity in cancer survivors: a cross-sectional study. Cardio-Oncology. 2019;5:1–6.
  • Brubaker P, Jensen A, Jordan J, et al. Exercise capacity is reduced in cancer survivors previously treated with anthracycline-based chemotherapy despite a preserved cardiac output response. JACC Cardiovasc Imaging. 2019;12:2267–2269.
  • Barber NJ, Ako EO, Kowalik GT, et al. Magnetic resonance-augmented cardiopulmonary exercise testing. Cir Cardiovasc Imaging. 2016;9:1–9.
  • La Gerche A, Claessen G, Van De Bruaene A, et al. Cardiac MRI: a new gold standard for ventricular volume quantification during high-intensity exercise. Cir Cardiovasc Imaging. 2013;6:329–338.
  • Roest AAW, Lamb HJ, van der Wall EE, et al. Cardiovascular response to physical exercise in adult patients after atrial correction for transposition of the great arteries assessed with magnetic resonance imaging. Heart. 2004;90:678–684.
  • Winter MM, Scherptong RWC, Kumar S, et al. Ventricular response to stress predicts outcome in adult patients with a systemic right ventricle. Am Heart J. 2010;160:870–876.
  • Roest AAW, Helbing WA, Kunz P, et al. Exercise MR imaging in the assessment of pulmonary regurgitation and biventricular function in patients after tetralogy of fallot repair. Radiology. 2002;223:204–211.
  • Holverda S, Gan CTJ, Marcus JT, et al. Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol. 2006;47:1732–1733.
  • Lin ACW, Strugnell WE, Seale H, et al. Exercise cardiac MRI-derived right ventriculo-Arterial coupling ratio detects early right ventricular maladaptation in PAH. Eur Respir J. 2016;48:1797–1800.
  • Holverda S, Rietema H, Westerhof N, et al. Stroke volume increase to exercise in chronic obstructive pulmonary disease is limited by increased pulmonary artery pressure. Heart. 2009;95:137–141.
  • Beaudry RI, Howden EJ, Foulkes S, et al. Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy. Physiol Rep. 2019;7:e13971–e13971.
  • Foulkes SJ, Howden EJ, Bigaran A, et al. Persistent impairment in cardiopulmonary fitness after breast cancer chemotherapy. Med Sci Sport Exer. 2019;51:1573–1581.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.